By Karen Roman Fashion brand accelerator a.k.a. Brands Holding Corp. (NYSE: AKA) said net sales rose 6.4% to $149.9 million in the third quarter, with U.S. net sales increasing 19.5%. Adjusted EBITDA was $8.2 million compared to $4.7 million in the...

By Karen Roman Radella Pharmaceuticals, LLC. announced the successful trial results of MD-18, its leading program to treat obesity and diabetes. The company will start the next phase applying multiple doses of MD-18 before the end of the year, it...

By Karen Roman Planet Fitness, Inc. (NYSE:PLNT) said revenue grew 5.3% to $292.2 million in the third quarter and adjusted EBITDA increased 10% to $123.1 million. Net income was $42 million or $0.50 per share, compared to $39.1 million or...

By Karen Roman Solo Brands, Inc. (NYSE: DTC) said it is maintaining its full year outlook with total revenue between $470 million to $490 million and an adjusted EBITDA margin from 9% to 10%. Net sales were $94.1 million decreasing...

By Karen Roman Chicago-style chain Portillo’s Inc. (Nasdaq: PTLO) said total revenue rose 6.9% to $178.3 million for the third quarter, while net income increased $2.2 million to $8.8 million. Earnings per share were $0.11, increasing 83.33% from the prior-year...

By Karen Roman Shake Shack Inc. (NYSE: SHAK) shares rose 7.79% at the closing after the company declared revenue grew 14.7% for the third quarter and same-store sales increased 4.4%, beating analysts’ expectations. This is the 15th consecutive quarter of...

By Exec Edge Editorial Staff Assailants on a motorcycle fired five shots into the car carrying Uzbekistan’s former press secretary Komil Allamjonov early Saturday morning near his home outside of the country’s capital of Tashkent. Both Allamjonov and his driver were...

By Karen Roman DecisionRx said it appointed Michael Tilton as Chief Growth Officer to lead the expansion of the company’s Medication Therapy Optimization platform. Tilton’s previous roles include senior vice president at Humana, as well as other senior leadership positions...

Tech Edge hosted a fireside chat on Oct. 23 at Nasdaq MarketSite with Kevin Lynch, Chief Executive Officer at Optiv. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed how AI is reshaping the landscape of election security, cyber...

By Daniella Parra Aktis Oncology said AKY-1189 is showing promise to treat cancers such as metastatic urothelial carcinoma, breast, lung, colorectal and cervical cancers. The company said data from an oral plenary and two posters highlighted significant tumor uptake and...